Table 2 Comparison of preferred treatment approaches in JIA between Canadian and German/Austrian pediatric rheumatology practitioners
Germany/Austria (N=109) | Canada (N=37) | P‡ | |
|---|---|---|---|
Initial treatment of oligoarticular JIA* | |||
NSAID | 92.5 | 86.1 | ns |
Intra-articular steroids | 56.1 | 47.2 | ns |
DMARDs | 7.5 | 11.1 | ns |
Oral steroids | 1.9 | 0 | ns |
Biologic agents | 0.9 | 0 | ns |
Treatment of refractory oligoarticular JIA* | |||
NSAID | 25.0 | 13.5 | ns |
Intra-articular steroids | 96.2 | 100.0 | ns |
DMARDs | 29.8 | 2.7 | <0.001 |
Oral steroids | 0 | 0 | ns |
Biologic agents | 0 | 0 | ns |
Treatment of uveitis in oligoarticular JIA* | |||
NSAID | 5.8 | 18.2 | ns |
DMARDs | 89.3 | 84.9 | ns |
Oral steroids | 17.5 | 3.0 | 0.043 |
Biologic agents | 13.6 | 0 | 0.022 |
Initial treatment of polyarticular JIA* | |||
NSAID | 85.3 | 77.8 | ns |
Intra-articular steroids | 29.4 | 11.1 | 0.041 |
DMARDs | 90.2 | 75.0 | 0.045 |
Oral steroids | 34.3 | 19.4 | ns |
Biologic agents | 1.0 | 0 | ns |
Preferred treatment of refractory polyarticular JIA** | 0.002 | ||
Switch to different DMARD | 2.1% | 20.6% | |
Additional DMARD | 11.7% | 14.7% | |
Intra-articular Steroids | 17.0% | 17.6% | |
Add or switch to biologic agents | 69.1% | 47.1% | |
Median time to change treatment of refractory polyarticular JIA (range)† | 3 months (1 – 9) | 3 months (1 – 9) | ns |
Median time to switch to biologic agents in refractory polyarticular JIA (range)† | 3 months (1 – 9) | 4 months (1 – 12) | ns |
Preferred physiotherapy recommendation for oligoarticular JIA** | <0.001 | ||
Regular physiotherapy | 85.6% | 13.9% | |
Home exercise after initial coaching | 14.4% | 52.8% | |
Encourage physical activity | 1.0% | 36.1% | |
Preferred physiotherapy recommendation for polyarticular JIA** | <0.001 | ||
Regular physiotherapy | 89.5% | 14.7% | |
Home exercise after initial coaching | 9.5% | 73.5% | |
Encourage physical activity | 1.0% | 11.8% | |